GlassScriptPhysician profile
John M Prpich
NPI 1316038466
$151,102.74
in general payments reported to CMS, 2019-2025
40 companies · $19K in 2025
The $19K reported for 2025 was more than what 98% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,639 · 2020: $9,751 · 2021: $29K · 2022: $37K · 2023: $20K · 2024: $28K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Food and Beverage: $8,954 · Travel and Lodging: $2,869 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,967.50 |
| Food and Beverage | $8,954.23 |
| Travel and Lodging | $2,869.03 |
| Education | $144.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $59,668.90 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $56,558.48 | 2019-2025 | Fasenra, Tezspire, Symbicort |
| Regeneron Healthcare Solutions, INC. | $16,975.04 | 2020-2025 | Dupixent |
| Sobi, INC | $3,642.23 | 2019-2024 | |
| Advanced Respiratory, INC | $2,047.48 | 2019-2021 | |
| Phadia US INC. | $1,970.43 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,963.26 | 2019-2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $981.44 | 2020-2025 | |
| Genentech USA, INC. | $951.77 | 2019-2025 | Xolair |
| Chiesi USA, INC. | $827.33 | 2019-2021 | |
| Amgen INC. | $784.52 | 2021-2025 | Tezspire |
| Baxter Healthcare | $744.58 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Covis Pharma Gmbh | $623.11 | 2019-2022 | |
| Hill-Rom Services, INC | $360.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $320.13 | 2020-2025 | Cuvitru, Hyqvia |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $310.90 | 2019-2024 | (Ae4) Secretion Management |
| Jazz Pharmaceuticals INC. | $235.74 | 2019-2021 | |
| Pfizer INC. | $226.94 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $194.74 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $159.11 | 2019-2022 | |
| Kaleo, INC. | $158.73 | 2020-2024 | Auvi-Q |
| Vapotherm INC | $154.95 | 2021-2022 | |
| Csl Behring | $140.00 | 2023-2025 | Hizentra |
| Gilead Sciences, INC. | $134.73 | 2019-2021 | |
| Harmony Biosciences LLC | $133.22 | 2024-2025 | |
| Shire North American Group INC | $121.61 | 2019 | |
| Insmed, INC. | $117.67 | 2025 | Arikayce, Brinsupri |
| Electromed, INC. | $94.75 | 2019-2025 | Smartvest |
| Regeneron Pharmaceuticals, INC. | $85.72 | 2022 | |
| Pharming Healthcare, INC. | $70.63 | 2022-2025 | Ruconest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.59 | 2019-2021 | |
| Allergan, INC. | $55.51 | 2019-2020 | |
| Masimo Corporation | $45.70 | 2020 | |
| Biogen, INC. | $41.16 | 2019-2020 | |
| Tactile Systems Technology INC | $39.97 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Alk-Abello, INC | $24.06 | 2023 | Standardized Mite D. Farinae, Timothy, Standardized, Alternaria Tenuis |
| Resmed Corp | $20.08 | 2024 | |
| Mission Pharmacal Company | $19.18 | 2019 | |
| Circassia INC. | $16.05 | 2020 | |
| Hikma Pharmaceuticals USA | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Prpich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.